Experimental drug shows promise for prostate cancer
March 24th, 2010 Posted in prostate cancerA company-led study found that an experimental drug has extended the lives of men with advanced prostate cancer who are no longer responding to other treatments and are out of options for fighting the disease.
The real benefit was modest - an extra 10 weeks - but cancer specialists were excited because no chemotherapy until now has been shown to boost survival in such men. And like any new drug tested on worst-case patients, there are hopes it will do better when tested in men who aren’t as sick.
The drug known as cabazitaxel, is made by the French company Sanofi-Aventis SA. The federal Food and Drug Administration has said it will give it a quick review, which means it could be on the market soon.